These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29779801)

  • 21. Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder.
    Gow RV; Matsudaira T; Taylor E; Rubia K; Crawford M; Ghebremeskel K; Ibrahimovic A; Vallée-Tourangeau F; Williams LM; Sumich A
    Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):151-6. PubMed ID: 19230637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
    Voigt RG; Llorente AM; Jensen CL; Fraley JK; Berretta MC; Heird WC
    J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIRS-based neurofeedback training in a virtual reality classroom for children with attention-deficit/hyperactivity disorder: study protocol for a randomized controlled trial.
    Blume F; Hudak J; Dresler T; Ehlis AC; Kühnhausen J; Renner TJ; Gawrilow C
    Trials; 2017 Jan; 18(1):41. PubMed ID: 28118856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial.
    Kean JD; Sarris J; Scholey A; Silberstein R; Downey LA; Stough C
    Psychopharmacology (Berl); 2017 Feb; 234(3):403-420. PubMed ID: 27921139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials.
    Händel MN; Rohde JF; Rimestad ML; Bandak E; Birkefoss K; Tendal B; Lemcke S; Callesen HE
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial.
    Mohammadpour N; Jazayeri S; Tehrani-Doost M; Djalali M; Hosseini M; Effatpanah M; Davari-Ashtiani R; Karami E
    Nutr Neurosci; 2018 Apr; 21(3):202-209. PubMed ID: 27924679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.
    Tesei A; Crippa A; Ceccarelli SB; Mauri M; Molteni M; Agostoni C; Nobile M
    Eur Child Adolesc Psychiatry; 2017 Sep; 26(9):1011-1030. PubMed ID: 27988864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.
    Cornu C; Mercier C; Ginhoux T; Masson S; Mouchet J; Nony P; Kassai B; Laudy V; Berquin P; Franc N; Le Heuzey MF; Desombre H; Revol O
    Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):377-384. PubMed ID: 28993963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The prevalence of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].
    Schlack R; Hölling H; Kurth BM; Huss M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007; 50(5-6):827-35. PubMed ID: 17514469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of nutritional interventions on the functioning of children with ADHD and/or ASD. An updated review of research evidence.
    Martí LF
    Bol Asoc Med P R; 2010; 102(4):31-42. PubMed ID: 21766545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials.
    Puri BK; Martins JG
    Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):179-89. PubMed ID: 24560325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD).
    Germano M; Meleleo D; Montorfano G; Adorni L; Negroni M; Berra B; Rizzo AM
    Nutr Neurosci; 2007; 10(1-2):1-9. PubMed ID: 17539477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial.
    Hirayama S; Terasawa K; Rabeler R; Hirayama T; Inoue T; Tatsumi Y; Purpura M; Jäger R
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():284-91. PubMed ID: 23495677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study.
    Hirayama S; Hamazaki T; Terasawa K
    Eur J Clin Nutr; 2004 Mar; 58(3):467-73. PubMed ID: 14985685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional supplements for the treatment of ADHD.
    Bloch MH; Mulqueen J
    Child Adolesc Psychiatr Clin N Am; 2014 Oct; 23(4):883-97. PubMed ID: 25220092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis.
    Cooper RE; Tye C; Kuntsi J; Vassos E; Asherson P
    J Psychopharmacol; 2015 Jul; 29(7):753-63. PubMed ID: 26040902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention deficit disorders--drugs or nutrition?
    Matsudaira T
    Nutr Health; 2007; 19(1-2):57-60. PubMed ID: 18309764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between behavioral symptoms of non-medicated Chinese children with attention deficit hyperactivity disorder and parenting stress: Comparison of different subtypes and comorbidities.
    Li Y; Jiang WQ; Du YS; Coghill D
    Asia Pac Psychiatry; 2016 Jun; 8(2):127-35. PubMed ID: 26403485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.